INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Total Non-Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹10 Cr | ₹11 Cr | ₹8.97 Cr | ₹8.10 Cr | ₹5.27 Cr |
What is the latest Total Non-Current Assets ratio of INDO US BIOTECH ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹10 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹8.97 Cr |
| Mar2022 | ₹8.10 Cr |
| Mar2021 | ₹5.27 Cr |
How is Total Non-Current Assets of INDO US BIOTECH Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹10 Cr | -2.66 | |
| Mar2024 | ₹11 Cr | 19.34 | |
| Mar2023 | ₹8.97 Cr | 10.73 | |
| Mar2022 | ₹8.10 Cr | 53.68 | |
| Mar2021 | ₹5.27 Cr | - | |
Compare Total Non-Current Assets of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹251.5 Cr | -2.5% | -3.8% | -55.7% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,043.2 Cr | 3.1% | -0.3% | -21.8% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,978.0 Cr | 2% | -9.4% | 2.9% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,003.9 Cr | 4.8% | 5.4% | -20.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,032.3 Cr | 0.2% | -16.1% | -39.6% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹492.7 Cr | 4.3% | 6.6% | 25.1% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -2.5% |
-3.8% |
-55.7% |
| SENSEX | -0.5% |
1% |
4.6% |
You may also like the below Video Courses